Yes, you can test positive for HPV after being vaccinated. The HPV vaccine is highly effective at preventing new infections from the strains it targets, but it does not eliminate infections you already had before vaccination, and it does not cover every strain of HPV. Either of these situations can lead to a positive test result in someone who is fully vaccinated.
Why Vaccination Doesn’t Guarantee a Negative Test
The most common vaccine used today (Gardasil 9) protects against nine HPV types, including the two high-risk strains responsible for more than 77% of cervical cancers worldwide. Against those key strains, the vaccine is at least 97% effective at preventing persistent infection. That’s excellent protection, but it leaves two important gaps.
First, there are over 200 types of HPV, and roughly 14 are considered high-risk for cancer. The vaccine covers the most dangerous ones, but not all of them. A screening test that checks for high-risk HPV can pick up strains the vaccine was never designed to block. Second, the vaccine is preventive, not therapeutic. If you were already infected with a vaccine-targeted strain before your shots, the vaccine will not clear that existing infection. Research published in 2025 confirmed this directly: vaccination was effective as a preventive measure but had no therapeutic effect on infections already present at the time of injection.
Pre-Existing Infections Are the Most Common Reason
HPV is so widespread that many people are exposed before they ever receive the vaccine. If you were vaccinated in your late teens or twenties rather than at the recommended age of 11 or 12, there’s a higher chance you had already picked up one or more strains. The vaccine cannot reverse that. Your immune system may eventually clear the infection on its own (most HPV infections do resolve within one to two years), but the vaccine itself won’t speed that process along.
This is also why health authorities recommend vaccination as early as possible. Getting vaccinated before any sexual contact gives the immune system a head start against strains you haven’t encountered yet. But even if you’re already sexually active, vaccination still offers meaningful protection because you’re unlikely to have been exposed to all nine strains in the vaccine.
Non-Vaccine Strains and Cross-Protection
When your cervical screening comes back HPV-positive, it typically detects a group of high-risk strains rather than identifying a single one. Some of those strains fall outside what the vaccine covers. HPV types 31, 33, 45, 52, and 58 are examples of high-risk strains that Gardasil 9 now includes, but earlier versions of the vaccine (the bivalent and quadrivalent formulas) did not protect against all of them.
Those older vaccines did show some cross-protection, meaning the immune response they triggered partially defended against related strains. But a large systematic review found this cross-protection was inconsistent and only reliably significant for HPV 31 and 45. The bivalent vaccine reduced persistent HPV 31 infections by roughly 65% to 79% in women who were HPV-negative at baseline. The quadrivalent vaccine reduced HPV 31 infections by about 46%. For other non-vaccine strains, protection was unreliable. So if you received an older vaccine, your window of vulnerability to certain strains was wider than with Gardasil 9.
How Much the Vaccine Reduces Overall HPV Rates
Even though a positive test is possible after vaccination, the vaccine dramatically lowers the odds. Population data from the U.S. comparing vaccinated and unvaccinated women ages 20 to 26 found that vaccinated women had a vaccine-type HPV prevalence of 7.4%, compared to 17.1% in unvaccinated women. That’s less than half the risk. These numbers reflect real-world conditions where some women were vaccinated after becoming sexually active, so the reduction would likely be even steeper in people vaccinated before any exposure.
Screening Recommendations Stay the Same
A common misconception is that vaccinated individuals can skip cervical cancer screening. That’s not the case. Current guidelines from the American College of Obstetricians and Gynecologists recommend that all individuals begin cervical cancer screening at age 21, regardless of vaccination status. For those aged 30 to 65, three options are recommended: a high-risk HPV test every five years, a Pap test alone every three years, or both tests together every five years.
As HPV vaccination rates climb and more vaccinated people reach screening age, overall HPV prevalence is expected to keep dropping. This could eventually push the screening start age to 25, as some organizations have already suggested. But for now, routine screening remains the standard because the vaccine, as effective as it is, does not eliminate every possible source of cervical cancer risk.
What a Positive Result Means for You
If you test positive for HPV after vaccination, it does not mean the vaccine failed. It most likely means one of three things: you had an infection before vaccination that hasn’t cleared yet, you were exposed to a strain the vaccine doesn’t cover, or you fall into the small percentage where the vaccine didn’t produce full immunity against a targeted strain. None of these scenarios is unusual, and most HPV infections resolve without causing any health problems.
A positive HPV test typically leads to closer monitoring rather than immediate treatment. Your provider may recommend a follow-up test in one to two years to see if your body clears the virus on its own, or a colposcopy (a closer look at the cervix) if there are signs of abnormal cell changes. The vast majority of HPV infections, even high-risk ones, never progress to cancer. Regular screening exists precisely to catch the rare cases that do, early enough to treat them effectively.